tradmap

PAVM Financials PAVmed Inc.

11 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has declined 38.6% per year over the past 5 years.

Financial health

  • Operating income covered interest expense -1038.4× in the latest year.
  • The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
-$89M -$29M $32M $0 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-30713% -14823% 1067% 0% 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-1808% -18% 1771% 0% 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$73M -$36M $0 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $39M $77M 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$71M $17M $104M $0 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $71000 -$4M -207.0% -30712.7% -11.1% -9.7% -$5M — $2M
2024 $3M $32M -61.6% -1485.4% -1281.2% 104.3% -$34M — $1M
2023 $2M -$66M -161.8% -2805.7% 123.1% -200.1% -$52M — $20M
2022 $377000 -$89M -858.6% -24161.0% 919.2% -164.8% -$73M — $40M
2021 $500000 -$50M -17.0% -10878.6% -81.6% -57.9% -$42M — $77M
2020 — -$34M — — -1807.8% -173.3% -$22M — $17M
2019 — -$16M — — 430.4% -227.3% -$13M — $6M
2018 — -$18M — — 776.3% -211.5% -$9M — $8M
2017 — -$10M — — 334.2% -580.6% -$7M — $2M
2016 — -$6M — — 1771.1% -649.2% — — $585680
2015 — -$2M — — -280.3% -146.3% — — $767268

Valuation over time

How the market has priced PAVM against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 2.8 5.5 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 2052.5 4105.0 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is PAVM growing its revenue and profit?

Over the past 5 years, PAVmed Inc.'s revenue has declined 38.6% per year. These are computed facts, not advice.

How much debt does PAVM have?

As of FY2025, PAVmed Inc. reported — of total debt against $2M of cash; operating income covered interest expense -1038.4×.

What is PAVM's profit margin?

In FY2025, gross margin was -207.0%, operating margin -30712.7%, and net margin -5315.5%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.